Severe Acute Hepatitis B Treated With Entecavir

被引：11
|
作者：
De Socio, Giuseppe Vittorio Luigi [1 ]
Sgrelli, Alessio [1 ]
Tosti, Andrea [1 ]
Baldelli, Franco [1 ]
机构：
[1] Univ Perugia, Santa Maria Misericordia Hosp, Dept Infect Dis, Perugia, Italy
来源：
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES | 2011年 / 3卷 / 01期
关键词：
D O I：
10.4084/MJHID.2011.010
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Hepatitis B virus (HBV) infection constitutes a serious global health problem. Nowadays there are divergent data regarding the use of antiviral drugs to treat acute hepatitis B. We present here a case of a 62-year-old man affected by severe acute hepatitis B with progressive worsening of clinical and hepatic function. The patient was treated with entecavir without critical side effects. We observed rapid clinical and laboratory improvements and the disappearance of hepatitis B surface antigen (HBsAg). The treatment with entecavir was protracted until 17th week when the antibody anti-HBs appeared. Entecavir should be carefully considered for the treatment of severe acute hepatitis B cases.
引用
收藏
页数：4
相关论文
共 50 条
  • [31] CccDNA reduction in chronic hepatitis B patients treated with entecavir versus lamivudine
    Co, Jonard
    Sollano, Jose
    Nilo, Grace
    Antonio, Felinor
    Dy, Frederick
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A9 - A10
  • [32] Severe cholestasis in a patient with acute hepatitis C treated with interferon α-2b
    Mukherjee, S
    Gilroy, RK
    Schaefer, DF
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (08): : 2152 - 2153
  • [33] Development and validation of a model for hepatitis B e antigen seroconversion in entecavir-treated patients with chronic hepatitis B
    Shen, Sheng
    Wong, Grace L. H.
    Kuang, Zhe
    van Campenhout, Margo J. H.
    Fan, Rong
    Wong, Vincent W. S.
    Yip, Terry C. F.
    Chi, Heng
    Liang, Xieer
    Hu, Xiaoyun
    Lin, Weiyin
    Wu, Yaobo
    Liu, Xiaoju
    Boonstra, Andre
    Hou, Jinlin
    Sun, Jian
    Chan, Henry L. Y.
    JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (08) : 1206 - 1213
  • [34] Pharmacotherapy of Chronic Hepatitis B with Entecavir
    Palumbo, Emilio
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 11 - 15
  • [35] Hepatitis B virus resistance to entecavir
    Hidalgo-Tenorio, Carmen
    Rivero, Mar
    Alvarez, Marta
    Garcia, Federico
    MEDICINA CLINICA, 2012, 139 (05): : 228 - 229
  • [36] Entecavir Efficiency in Chronic Hepatitis B
    Grecu, Nicolae
    Preda, Carmen
    Soare, Alina
    Stefan, Gabriel
    Andrei, Stefan
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2011, 16 : 31 - 32
  • [37] Entecavir for chronic hepatitis B: A review
    Palumbo, Emilio
    THERAPEUTIC DRUG MONITORING, 2008, 30 (01) : 1 - 4
  • [38] Entecavir (Baraclude) for chronic hepatitis B
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2005, 47 (1210): : 47 - 48
  • [39] Lamivudine and Entecavir for Acute Hepatitis B: A Systematic Review and Meta-Analysis
    Henriquez-Camacho, Cesar
    Hijas-Gomez, Ana Isabel
    Risco, Carlos Risco
    Lapuente, Maria Angeles Ruiz
    Escudero-Sanchez, Rosa
    Cuerda, Victor Moreno
    VIRUSES-BASEL, 2023, 15 (11):
  • [40] Entecavir of 1.0 mg daily with acute on chronic hepatitis B liver failure
    Zhang, Qianqian
    Guo, Xiaolin
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 917 - 917
12345